Afsheen A. Shah
- BIOGRAPHY
- News
- Insights
Afsheen Shah focuses primarily on representing hospitals, nursing homes and physician groups in negotiating a wide variety of contractual arrangements, including IT agreements, clinical research agreements, and procurement and purchasing agreements. Afsheen has also assisted multiple nursing home clients in meeting their compliance and regulatory obligations under both federal and state law and navigating government audits. Afsheen has also assisted clients in successfully implementing and satisfying critical obligations under the requirements of corporate integrity agreements and ensuring proper compliance with applicable state and federal regulations.
Prior to joining the firm’s healthcare group, Afsheen spent 15 years representing chapter 11 debtors, creditors’ committees, individual creditors and creditor constituencies in various corporate and healthcare reorganizations and other high profile bankruptcy filings.
Thirty-Eight Garfunkel Wild attorneys were selected by their peers for inclusion in the 2024 editions of The Best Lawyers in America and The Best Lawyers: Ones to Watch.
Thirty Five Garfunkel Wild attorneys were selected by their peers for inclusion in the 2023 The Best Lawyers in America® guide and the Best Lawyers “Ones to Watch” list. In addition, Partner Jason Y. Hsi was honored as “Lawyer of the Year” in the area of Litigation – Health Care Law.
Garfunkel Wild received prominent recognition in the 2025 editions of The Best Lawyers in America and The Best Lawyers in America: Ones to Watch. A total of 38 attorneys were honored with 59 individual recognitions across various practices and offices nationwide. Additionally, 3 Garfunkel Wild attorneys were distinguished as Lawyer of the Year, an accolade awarded to only one […]
Garfunkel Wild received prominent recognition in the 2026 editions of The Best Lawyers in America® and The Best Lawyers in America: Ones to Watch®. A total of 31 attorneys were honored with 47 individual recognitions across various practice areas and offices nationwide. Additionally, 1 Garfunkel Wild attorney was distinguished as Lawyer of the Year in Long Island for Litigation - Health Care, an accolade awarded to only one lawyer per practice area in each major U.S. market.
In the latest challenge to hospitals’ rights to use contract pharmacies, drug manufacturers targeted a Maryland law that barred them from restricting shipments of 340B drugs to contract pharmacies. In a disappointing turn for hospitals, the Fourth Circuit sided with the manufacturers and overturned a lower court ruling that had favored the state, clearing the way for the manufacturer’s unilateral restrictions to potentially move forward. This ruling contrasts earlier decisions issued by other courts, which had generally favored states who had issued laws similar to that enacted by Maryland.
In yet another escalation of data transparency requirements, AstraZeneca has joined the ranks of Eli Lilly and Novo Nordisk and announced that effective May 1, 2026, covered entities must submit pharmacy and medical claims data for all 340B purchases, including in-house pharmacy dispensations, as a condition of accessing 340B pricing.
In this Health Care Information and Technology Podcast, we discuss the top three health care IT contract mistakes that medical providers make and how to avoid them.
The U.S. Department of Health and Human Services, Office of Inspector General (OIG) posted a favorable Advisory Opinion (23-11) that allows a medical device manufacturer (Manufacturer) to subsidize Medicare cost-sharing obligations as part of a U.S. Food & Drug Administration (FDA)-approved clinical study involving a Category B Investigational Device Exemption.
Afsheen A. Shah will present at the Healthcare Financial Management Association’s (Hfma) Metropolitan New York Chapter Regulatory Compliance Seminar December 11, 2019.
Additional speaking & writing
Speeches and Events
- Speaker – National Employment Lawyers Association, Fall Conference “A Bankruptcy Overview for the Employment Litigator. (October 23, 2020)
- When a Small Case Becomes a Big Case: Keeping E-Discovery Cost in Check” (South Asian Bar Association of North America (SABA North America) Annual Conference, New York, NY (June 29, 2018)
Publications
- Authored chapter entitled “Regulated Medical Waste” and co-authored “Committee for Physicians’ Health and Physician Impairment” in the Legal Manual of New York Physicians (Sixth Edition)
- The Hazards of Pharmaceutical Disposal: Rising Issues of Concern for Healthcare, HFMA’s New Jersey Chapter Garden State Focus, November/December 2010, Vol 57, Number 3
Afsheen Shah focuses primarily on representing hospitals, nursing homes and physician groups in negotiating a wide variety of contractual arrangements, including IT agreements, clinical research agreements, and procurement and purchasing agreements. Afsheen has also assisted multiple nursing home clients in meeting their compliance and regulatory obligations under both federal and state law and navigating government audits. Afsheen has also assisted clients in successfully implementing and satisfying critical obligations under the requirements of corporate integrity agreements and ensuring proper compliance with applicable state and federal regulations.
Prior to joining the firm’s healthcare group, Afsheen spent 15 years representing chapter 11 debtors, creditors’ committees, individual creditors and creditor constituencies in various corporate and healthcare reorganizations and other high profile bankruptcy filings.
The U.S. Department of Health and Human Services, Office of Inspector General (OIG) posted a favorable Advisory Opinion (23-11) that allows a medical device manufacturer (Manufacturer) to subsidize Medicare cost-sharing obligations as part of a U.S. Food & Drug Administration (FDA)-approved clinical study involving a Category B Investigational Device Exemption.
Afsheen A. Shah will present at the Healthcare Financial Management Association’s (Hfma) Metropolitan New York Chapter Regulatory Compliance Seminar December 11, 2019.
In this Health Care Information and Technology Podcast, we discuss the top three health care IT contract mistakes that medical providers make and how to avoid them.
In yet another escalation of data transparency requirements, AstraZeneca has joined the ranks of Eli Lilly and Novo Nordisk and announced that effective May 1, 2026, covered entities must submit pharmacy and medical claims data for all 340B purchases, including in-house pharmacy dispensations, as a condition of accessing 340B pricing.
In the latest challenge to hospitals’ rights to use contract pharmacies, drug manufacturers targeted a Maryland law that barred them from restricting shipments of 340B drugs to contract pharmacies. In a disappointing turn for hospitals, the Fourth Circuit sided with the manufacturers and overturned a lower court ruling that had favored the state, clearing the way for the manufacturer’s unilateral restrictions to potentially move forward. This ruling contrasts earlier decisions issued by other courts, which had generally favored states who had issued laws similar to that enacted by Maryland.
In the latest challenge to hospitals’ rights to use contract pharmacies, drug manufacturers targeted a Maryland law that barred them from restricting shipments of 340B drugs to contract pharmacies. In a disappointing turn for hospitals, the Fourth Circuit sided with the manufacturers and overturned a lower court ruling that had favored the state, clearing the way for the manufacturer’s unilateral restrictions to potentially move forward. This ruling contrasts earlier decisions issued by other courts, which had generally favored states who had issued laws similar to that enacted by Maryland.
In yet another escalation of data transparency requirements, AstraZeneca has joined the ranks of Eli Lilly and Novo Nordisk and announced that effective May 1, 2026, covered entities must submit pharmacy and medical claims data for all 340B purchases, including in-house pharmacy dispensations, as a condition of accessing 340B pricing.
In this Health Care Information and Technology Podcast, we discuss the top three health care IT contract mistakes that medical providers make and how to avoid them.
The U.S. Department of Health and Human Services, Office of Inspector General (OIG) posted a favorable Advisory Opinion (23-11) that allows a medical device manufacturer (Manufacturer) to subsidize Medicare cost-sharing obligations as part of a U.S. Food & Drug Administration (FDA)-approved clinical study involving a Category B Investigational Device Exemption.
Afsheen A. Shah will present at the Healthcare Financial Management Association’s (Hfma) Metropolitan New York Chapter Regulatory Compliance Seminar December 11, 2019.
Additional speaking & writing
Speeches and Events
- Speaker – National Employment Lawyers Association, Fall Conference “A Bankruptcy Overview for the Employment Litigator. (October 23, 2020)
- When a Small Case Becomes a Big Case: Keeping E-Discovery Cost in Check” (South Asian Bar Association of North America (SABA North America) Annual Conference, New York, NY (June 29, 2018)
Publications
- Authored chapter entitled “Regulated Medical Waste” and co-authored “Committee for Physicians’ Health and Physician Impairment” in the Legal Manual of New York Physicians (Sixth Edition)
- The Hazards of Pharmaceutical Disposal: Rising Issues of Concern for Healthcare, HFMA’s New Jersey Chapter Garden State Focus, November/December 2010, Vol 57, Number 3
Practices
Education
- Dean’s List
- Dean’s List
Court admissions
New York Supreme Court, Appellate Division
U.S. District Court: Southern District of New York
U.S. District Court: Eastern District of New York
U.S. Court of Appeals: Second Circuit
PROFESSIONAL MEMBERSHIPS
- New York State Bar Association
- Member of the American Bar Association Advisory Panel
AWARDS & RANKINGS
- Best Lawyers in America® – Health Care Law (2023-2026)
- New York Super Lawyers – Rising Stars (2013)